Status:

COMPLETED

Baby Observational and Nutritional Study

Lead Sponsor:

Seattle Children's Hospital

Collaborating Sponsors:

Cystic Fibrosis Foundation

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Cystic Fibrosis

Growth Failure

Eligibility:

All Genders

Up to 3 years

Brief Summary

Cystic fibrosis (CF) is a life-shortening disease that causes breathing and digestive problems, but can now be diagnosed at the time of birth. Lung function is very hard to measure in infants, but gro...

Detailed Description

Newborn screening (NBS) for cystic fibrosis (CF) has decreased the prevalence of malnutrition in infancy, but suboptimal nutrition still persists. In one study, 60% of infants diagnosed by NBS achieve...

Eligibility Criteria

Inclusion

  • Observational Study
  • Signed informed consent
  • Males or females no more than three and one half (3.5) months of age at enrollment
  • Documentation of a CF diagnosis as evidenced by:
  • One or more of the following: one or more clinical features consistent with the CF phenotype OR a positive newborn screening (NBS) OR a positive pre-natal screen
  • AND
  • One or more of the following: sweat chloride ≥ 60 mEq/liter by quantitative pilocarpine iontophoresis test (QPIT) OR two well-characterized mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
  • Enrolled in the Cystic Fibrosis Foundation Patient Registry. (Patients may enroll in the Registry at Enrollment Visit if not previously enrolled.)

Exclusion

  • Children unable to take full oral feeds
  • Any serious or active medical condition, which in the opinion of the investigator, contributes to malabsorption, interferes with normal growth, or would otherwise interfere with subject's treatment, assessment, or compliance with the protocol.
  • Gestational age less than 35 weeks and/or birth weight \< 2.5 kg.

Key Trial Info

Start Date :

December 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2015

Estimated Enrollment :

231 Patients enrolled

Trial Details

Trial ID

NCT01424696

Start Date

December 1 2011

End Date

April 1 2015

Last Update

September 28 2015

Active Locations (28)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (28 locations)

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35233

2

Arkansas Children's Hospital

Little Rock, Arkansas, United States, 72202

3

Children's Hospital Colorado

Aurora, Colorado, United States, 80045

4

Emory CF Center

Atlanta, Georgia, United States, 30322